NASDAQ: DTIL
Precision Biosciences Inc Stock Forecast, Predictions & Price Target

Analyst price target for DTIL

Based on 1 analyst offering 12 month price targets for Precision Biosciences Inc

Min Forecast
$30.00+265.85%
Avg Forecast
$30.00+265.85%
Max Forecast
$30.00+265.85%

Should I buy or sell DTIL stock?

Based on 1 analyst offering ratings for Precision Biosciences Inc.

Strong Buy
Strong Buy
1 analysts 100%
Buy
0 analysts 0%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although DTIL's forecast from analysts indicates a "Strong Buy", our proven Zen Rating quant model rates DTIL as a "Hold". Stocks with a Zen Rating of Hold have had an average return of +7.53% per year. Learn More

Be the first to know when Wall Street analysts revise their DTIL stock forecasts and price targets.

DTIL stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2026-04-17

1 of 1

Forecast return on equity

Is DTIL forecast to generate an efficient return?

Company
-96.83%
Industry
75.1%
Market
170.33%
DTIL's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is DTIL forecast to generate an efficient return on assets?

Company
-51.21%
Industry
28.98%
DTIL is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

DTIL earnings per share forecast

What is DTIL's earnings per share in the next 3 years based on estimates from 6 analysts?

Avg 1 year Forecast
-$2.91
Avg 2 year Forecast
-$2.74
Avg 3 year Forecast
-$2.75

DTIL revenue forecast

What is DTIL's revenue in the next 3 years based on estimates from 6 analysts?

Avg 1 year Forecast
$13.3M-70.41%
Avg 2 year Forecast
$13.2M-70.81%
Avg 3 year Forecast
$13.8M-69.45%
DTIL's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

DTIL revenue growth forecast

How is DTIL forecast to perform vs Biotechnology companies and vs the US market?

Company
-32.87%
Industry
33.66%
Market
13.98%
DTIL's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
DTIL's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

DTIL vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
DTIL$8.20$30.00+265.85%Strong Buy
TNXP$13.28$22.00+65.66%Strong Buy
CRBP$11.43$51.67+352.03%Strong Buy
MDWD$16.13$36.00+123.19%Buy
TNYA$1.00$5.33+433.30%Strong Buy

Precision Biosciences Stock Forecast FAQ

Is Precision Biosciences Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: DTIL) stock is to Strong Buy DTIL stock.

Out of 1 analyst, 1 (100%) are recommending DTIL as a Strong Buy, 0 (0%) are recommending DTIL as a Buy, 0 (0%) are recommending DTIL as a Hold, 0 (0%) are recommending DTIL as a Sell, and 0 (0%) are recommending DTIL as a Strong Sell.

If you're new to stock investing, here's how to buy Precision Biosciences stock.

What is DTIL's earnings growth forecast for 2026-2028?

(NASDAQ: DTIL) Precision Biosciences's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 15.2%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 34.27%.

Precision Biosciences's earnings in 2026 is -$43,600,000.On average, 6 Wall Street analysts forecast DTIL's earnings for 2026 to be -$75,007,132, with the lowest DTIL earnings forecast at -$111,259,289, and the highest DTIL earnings forecast at -$31,698,060. On average, 6 Wall Street analysts forecast DTIL's earnings for 2027 to be -$70,731,700, with the lowest DTIL earnings forecast at -$96,087,568, and the highest DTIL earnings forecast at -$38,742,074.

In 2028, DTIL is forecast to generate -$70,992,302 in earnings, with the lowest earnings forecast at -$83,444,467 and the highest earnings forecast at -$53,101,024.

What is DTIL's revenue growth forecast for 2026-2028?

(NASDAQ: DTIL) Precision Biosciences's forecast annual revenue growth rate of -32.87% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 33.66%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.98%.

Precision Biosciences's revenue in 2026 is $45,073,000.On average, 6 Wall Street analysts forecast DTIL's revenue for 2026 to be $344,124,568, with the lowest DTIL revenue forecast at $0, and the highest DTIL revenue forecast at $801,933,837. On average, 6 Wall Street analysts forecast DTIL's revenue for 2027 to be $339,505,966, with the lowest DTIL revenue forecast at $0, and the highest DTIL revenue forecast at $658,344,332.

In 2028, DTIL is forecast to generate $355,296,941 in revenue, with the lowest revenue forecast at $0 and the highest revenue forecast at $728,784,467.

What is DTIL's forecast return on assets (ROA) for 2026-2029?

(NASDAQ: DTIL) forecast ROA is -51.21%, which is lower than the forecast US Biotechnology industry average of 28.98%.

What is DTIL's Price Target?

According to 1 Wall Street analyst that have issued a 1 year DTIL price target, the average DTIL price target is $30.00, with the highest DTIL stock price forecast at $30.00 and the lowest DTIL stock price forecast at $30.00.

The Wall Street analyst predicted that Precision Biosciences's share price could reach $30.00 by Apr 17, 2027. The average Precision Biosciences stock price prediction forecasts a potential upside of 265.85% from the current DTIL share price of $8.20.

What is DTIL's Earnings Per Share (EPS) forecast for 2026-2028?

(NASDAQ: DTIL) Precision Biosciences's current Earnings Per Share (EPS) is -$2.14. On average, analysts forecast that DTIL's EPS will be -$2.91 for 2026, with the lowest EPS forecast at -$4.31, and the highest EPS forecast at -$1.23. On average, analysts forecast that DTIL's EPS will be -$2.74 for 2027, with the lowest EPS forecast at -$3.72, and the highest EPS forecast at -$1.50. In 2028, DTIL's EPS is forecast to hit -$2.75 (min: -$3.23, max: -$2.06).

What is DTIL's forecast return on equity (ROE) for 2026-2029?

(NASDAQ: DTIL) forecast ROE is -96.83%, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.